Abstract
Infants of women infected with hepatitis B virus (HBV) are at risk of acquiring hepatitis B, usually at the time of delivery but occasionally in utero or after delivery. Perinatally acquired HBV infections are noteworthy for their tendency to persist throughout life, predisposing victims to cirrhosis and hepatocellular carcinoma. In most instances perinatal infection can be prevented by combined passive-active immunization of infants at risk. It is recommended that attempts be made to identify pregnant women infected with HBV and that their infants be given hepatitis B immune globulin soon after birth, then be actively immunized with HBV vaccine. This approach is effective and safe and is subsidized in many provinces.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beasley R. P., Hwang L. Y., Lee G. C., Lan C. C., Roan C. H., Huang F. Y., Chen C. L. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983 Nov 12;2(8359):1099–1102. doi: 10.1016/s0140-6736(83)90624-4. [DOI] [PubMed] [Google Scholar]
- Beasley R. P., Hwang L. Y., Lin C. C., Stevens C. E., Wang K. Y., Sun T. S., Hsieh F. J., Szmuness W. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet. 1981 Aug 22;2(8243):388–393. doi: 10.1016/s0140-6736(81)90832-1. [DOI] [PubMed] [Google Scholar]
- Beasley R. P., Hwang L. Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983 Feb;147(2):185–190. doi: 10.1093/infdis/147.2.185. [DOI] [PubMed] [Google Scholar]
- Blumberg B. S., London W. T. Hepatitis B virus and the prevention of primary hepatocellular carcinoma. N Engl J Med. 1981 Mar 26;304(13):782–784. doi: 10.1056/NEJM198103263041312. [DOI] [PubMed] [Google Scholar]
- Krugman S. The newly licensed hepatitis B vaccine. Characteristics and indications for use. JAMA. 1982 Apr 9;247(14):2012–2015. [PubMed] [Google Scholar]
- Larke R. P., Haworth J. C., Read J. H. Breast-feeding by mothers positive for HBsAG. Can Med Assoc J. 1977 Jun 18;116(12):1344–1344. [PMC free article] [PubMed] [Google Scholar]
- Mulley A. G., Silverstein M. D., Dienstag J. L. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med. 1982 Sep 9;307(11):644–652. doi: 10.1056/NEJM198209093071103. [DOI] [PubMed] [Google Scholar]
- Nordenfelt E., Dahlquist E. HBsAg positive adopted children as a cause of intrafamilial spread of hepatitis B. Scand J Infect Dis. 1978;10(3):161–163. doi: 10.3109/inf.1978.10.issue-3.01. [DOI] [PubMed] [Google Scholar]
- Prozesky O. W., Stevens C. E., Szmuness W., Rolka H., Harley E. J., Kew M. C., Scholtz J. E., Mitchell A. D. Immune response to hepatitis B vaccine in newborns. J Infect. 1983 Jul;7 (Suppl 1):53–55. doi: 10.1016/s0163-4453(83)96649-5. [DOI] [PubMed] [Google Scholar]
- Stevens C. E., Taylor P. E., Rubinstein P., Ting R. C., Bodner A. J., Sarngadharan M. G., Gallo R. C. Safety of the hepatitis B vaccine. N Engl J Med. 1985 Feb 7;312(6):375–376. doi: 10.1056/NEJM198502073120613. [DOI] [PubMed] [Google Scholar]
- Stevens C. E., Toy P. T., Tong M. J., Taylor P. E., Vyas G. N., Nair P. V., Gudavalli M., Krugman S. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA. 1985 Mar 22;253(12):1740–1745. [PubMed] [Google Scholar]